Strategy

<div class="articleWrapper"><div class="articleContent"><h1 class="text title">Bridge to innovation</h1><h2 class="title-bottom webtitle">Why Chinese biopharmas are building beachheads in Boston</h2><div class="byline">Stephen Hansen, Associate Editor</div><div class="date">September 29, 2017 11:17 PM GMT</div>  </div></div>

Canbridge Pharmaceuticals Inc.

Luye Pharma Group Ltd.

New WuXi Life Science Ltd.

Qilu Pharmaceutical Co. Ltd.

Boston

China

Vcanbio Cell & Gene Engineering Corp. Ltd.

Bridge to innovation

A first wave of Chinese biopharmas has picked Boston to expand into innovative drug development based on access to talent and translational science.

Why Chinese biopharmas are building beachheads in Boston

Featured Analysis

Articles

Current Editions

Data Graphics

Podcasts & Webcasts

Special Reports & Presentations

White Papers

Analysis

BCIQ

Company Profiles

Product Profiles

Target Profiles

Financial Dashboards

BCIQ Data

All Events

China Healthcare Summit

Bio€quity Europe

Events

My Workspace

Company Overview

Management

Editorial & Research Team

Scientific Advisory Board

About BioCentury

Contact Us

Forgot Password

Trial

Subscribe

Advertising & Sponsorship

Career Opportunities

Customer Resource Center

Contact

Home